Not yet a member?
Print This Post
view / write comments
Interesting: pts. w/KRAS mutations, EGFR wild type (no mut’n), & those w/non-squamous NSCLC do esp well w/ARQ-197 w/Tarceva. #ASCO10
Related posts:
Related posts brought to you by Yet Another Related Posts Plugin.
Posted in: Tweets email to a friend
Print This Post
No Comments
Login (Must Be Logged In To Comment)